ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abraham, V. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Abraham, V. S.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 2000;69:506
© 2000 The Society of Thoracic Surgeons

Invited Commentaries

V. Simon Abraham, MDa

a Division of Cardiovascular and Thoracic Surgery, University of Kentucky College of Medicine, MN276, 800 Rose St, Lexington, KY 40536-0084, USA

Invited commentary

Low output states leading to inadequate renal perfusion, atherosclerosis, diabetes, and nephrotoxins in the form of dyes and antibiotics all conspire to make patients undergoing cardiac surgery a high-risk population for renal failure. Most patients who develop acute renal failure (ARF) suffer from progressive low cardiac output. Some patients, such as those studied in this . . . [Full Text of this Article]


Related Article

Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery
Srikrishna Sirivella, Isaac Gielchinsky, and Victor Parsonnet
Ann. Thorac. Surg. 2000 69: 501-506. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.